[Retracted] Albiflorin Alleviates Ox‐LDL‐Induced Human Umbilical Vein Endothelial Cell Injury through IRAK1/TAK1 Pathway

Yeling Liu, Yilai Sun, Xue Bai, Lingxing Li, Guihua Zhu

Open source

DOI
10.1155/2022/6584645
Published
2022-01
Container
BioMed Research International
Publisher
Wiley
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/2022/6584645,
  title = {[Retracted] Albiflorin Alleviates Ox‐LDL‐Induced Human Umbilical Vein Endothelial Cell Injury through IRAK1/TAK1 Pathway},
  author = {Yeling Liu and Yilai Sun and Xue Bai and Lingxing Li and Guihua Zhu},
  year = {2022},
  journal = {BioMed Research International},
  doi = {10.1155/2022/6584645},
  url = {https://doi.org/10.1155/2022/6584645}
}

RIS

TY  - JOUR
TI  - [Retracted] Albiflorin Alleviates Ox‐LDL‐Induced Human Umbilical Vein Endothelial Cell Injury through IRAK1/TAK1 Pathway
AU  - Yeling Liu
AU  - Yilai Sun
AU  - Xue Bai
AU  - Lingxing Li
AU  - Guihua Zhu
PY  - 2022
JO  - BioMed Research International
DO  - 10.1155/2022/6584645
UR  - https://doi.org/10.1155/2022/6584645
ER  - 

APA

Liu, Y., Sun, Y., Bai, X., Li, L., & Zhu, G. (2022). [Retracted] Albiflorin Alleviates Ox‐LDL‐Induced Human Umbilical Vein Endothelial Cell Injury through IRAK1/TAK1 Pathway. BioMed Research International. https://doi.org/10.1155/2022/6584645

Source records